Francisco J. Esteva - Researcher Profile

Publications

2 shown

Prognostic molecular markers in early breast cancer

Francisco J. Esteva , Gabriel N. Hortobágyi

2004 Breast Cancer Research 249 citations

Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: MONALEESA-3

Dennis J. Slamon , Patrick Neven , Stephen Chia +18 more

Purpose This phase III study evaluated ribociclib plus fulvestrant in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast c...

2018 Journal of Clinical Oncology 1036 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 1,285
Institution: The University of Texas MD Anderson Cancer Center

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-2437-3920

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.